JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 108:1303-1310
© 2009 International Anesthesia Research Society
doi: 10.1213/ane.0b013e318193e919
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shih, C.-M.
Right arrow Articles by Chou, T.-C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Shih, C.-M.
Right arrow Articles by Chou, T.-C.
Related Collections
Right arrow Mechanisms
Right arrow Pain Mechanisms
Right arrow Preclinical Pharmacology
Right arrow Pharmacology


ANALGESIA

Antiinflammatory and Antihyperalgesic Activity of C-Phycocyanin

Chao-Ming Shih, MD*, Shin-Nan Cheng, MD, PhD{dagger}, Chih-Shung Wong, MD, PhD{ddagger}, Yu-Ling Kuo, MS§, and Tz-Chong Chou, PhD§

From the *Chia-Yi Christian Hospital; {dagger}Department of Pediatrics, Tri-Service General Hospital, National Defense Medical Center; {ddagger}Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center; and §Department of Physiology, National Defense Medical Center, Taipei, Taiwan, Republic of China.

Address correspondence and reprint requests to Tz-Chong Chou, PhD, Department of Physiology, National Defense Medical Center, No. 161, Min-Chuan E. Rd., Sec. 6, Taipei, Taiwan, Republic of China. Address e-mail to tcchou{at}ms5.hinet.net.

Abstract

BACKGROUND: C-phycocyanin (C-PC), a biliprotein found in blue green algae, such as Spirulina platensis, is often used as a dietary nutritional supplement due to its various therapeutic values. In addition, the antiinflammatory activity of C-PC partly through inhibition of proinflammatory cytokine formation, inducible nitric oxide synthase (iNOS) and cyclooxygeanase-2 (COX-2) expression has been demonstrated in many in vitro and in vivo studies. However, whether C-PC also has antihyperalgesic activity in inflammatory nociception has not been investigated.

METHODS: Using a carrageenan-induced thermal hyperalgesia model, we evaluated the effect of C-PC on nociception by measuring paw withdrawal latency. To clarify the mechanisms involved, the expression of iNOS and COX-2 and the formation of nitrate and tumor necrosis factor-{alpha} (TNF-{alpha}) in the rat paw were determined.

RESULTS: Pre- or posttreatment with C-PC (30 or 50 mg/kg, IP) significantly attenuated carrageenan-induced inflammatory nociception and the induction of iNOS and COX-2 at the late phase, (4 h) accompanied by an inhibition of the formation of TNF-{alpha}, prostaglandin E2, nitrate and myeloperoxidase activity.

CONCLUSIONS: Based on these results, it is suggested that the inhibition of NO and prostaglandin E2 over-production through suppressing iNOS and COX-2 induction and attenuation of TNF-{alpha} formation and neutrophil infiltration into inflammatory sites by C-PC may contribute, at least in part, to its antihyperalgesic activity.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.